Engineers Gate Manager’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
14,979
-1,018
-6% -$81.7K 0.02% 958
2026
Q1
$1.23M Sell
15,997
-4,605
-22% -$359K 0.02% 939
2025
Q4
$1.63M Buy
20,602
+17,693
+608% +$1.53M 0.02% 804
2025
Q3
$266K Buy
+2,909
New +$237K ﹤0.01% 1793
2024
Q4
Sell
-4,093
Closed -$244K 2205
2024
Q3
$244K Buy
+4,093
New +$250K ﹤0.01% 1719
2023
Q3
Sell
-4,506
Closed -$243K 1775
2023
Q2
$243K Buy
+4,506
New +$200K 0.01% 1395
2021
Q3
Sell
-8,411
Closed -$295K 1617
2021
Q2
$295K Sell
8,411
-1,270
-13% -$43.2K 0.02% 1152
2021
Q1
$350K Sell
9,681
-2,430
-20% -$76.1K 0.02% 1216
2020
Q4
$352K Sell
12,111
-240
-2% -$6.87K 0.02% 1195
2020
Q3
$348K Sell
12,351
-18,163
-60% -$541K 0.02% 1168
2020
Q2
$987K Buy
+30,514
New +$1.09M 0.05% 603
2019
Q1
Sell
-5,441
Closed -$245K 920
2018
Q4
$245K Buy
+5,441
New +$285K 0.02% 699
2018
Q3
Sell
-10,005
Closed -$668K 897
2018
Q2
$668K Buy
+10,005
New +$625K 0.05% 462

Other funds holding ANIP

Engineers Gate Manager's ANIP Position: Q2 2026 in Review

Engineers Gate Manager reduced its ANI Pharmaceuticals (ANIP) stake by 6.4% in Q2 2026, selling an estimated $81.7K and leaving 14,979 shares worth $1.24M. The position accounts for 0.02% of the portfolio, ranked #958.

Engineers Gate Manager first reported a position in ANIP in Q2 2018 and has held it in 13 quarters since. The position peaked at $1.63M in Q4 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Engineers Gate Manager held 14,979 shares of ANI Pharmaceuticals worth $1.24M as of Q2 2026.
  • Engineers Gate Manager sold 1,018 ANI Pharmaceuticals shares in Q2 2026, an estimated $81.7K.
  • ANI Pharmaceuticals made up 0.02% of Engineers Gate Manager's portfolio in Q2 2026, its #958 holding.
  • Engineers Gate Manager first reported a position in ANI Pharmaceuticals in Q2 2018 and has held it in 13 quarters since.
  • Engineers Gate Manager's ANI Pharmaceuticals position peaked at $1.63M in Q4 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.